Source link : https://newshealth.biz/health-news/new-first-line-option-for-advanced-bladder-cancer/
The National Institute for Health and Care Excellence (NICE) has recommended the combination of enfortumab vedotin (Padcev, Astellas) with pembrolizumab (Keytruda, MSD) as a first-line option for adults with unresectable or metastatic urothelial cancer who are eligible for platinum-based chemotherapy. More than 1200 people in England are expected to benefit each year. Clinical experts described the […]
The post New First-Line Option for Advanced Bladder Cancer first appeared on News Health.
—-
Author : News Health
Publish date : 2025-08-21 14:50:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8